Mr Mark Louis Vidallon
Honorary (Senior Fellow)
Baker Department of Cardiometabolic Health
6 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
Platelet-Targeted Self-Amplifying mRNA for Safe, Long-Acting Thromboprophylaxis
DOI: 10.1161/CIRCRESAHA.125.3276262026
Journal article
CD39 mRNA therapy attenuates localized acute inflammation: A novel anti-inflammatory strategy using cationic nanoliposomes
DOI: 10.1016/j.omtn.2026.1029662026
Journal article
Spatio-temporal targeting of cardiac cells with lipid nanoparticles after myocardial infarction
DOI: 10.1016/j.jmccpl.2026.1008502026
Journal article
Dual Stimuli-Responsive Polylipoamide Nanoparticles as a Versatile Platform for Efficient pDNA and mRNA Delivery
DOI: 10.1002/sstr.705072025
Research grants (other domestic)
Precision Prevention: Novel mRNA Encoding Platelet Blocking Antibody for Targeted Thrombosis Management
2024
Research grants (other domestic)
Novel mRNA-based Therapeutics: An Innovative Controlled-Release Nanodelivery Approach to Treat Inflammation-Related Cardiovascular Diseases
2024
Research grants (other domestic)
Innovative Bioengineering of Nanodelivery Systems With mRNA-based Therapeutics for Inflammatory and Cardiovasculardiseases
RECENT SCHOLARLY WORKS
2025
Journal article
Unlocking the Architecture and Component Distribution of Bioengineered and Derived Colloidal Structures from Blood with Neutron Scattering
DOI: 10.1002/sstr.2025003692025
Journal article
Polydopamine Nanobowl-Armoured Perfluorocarbon Emulsions: Tracking Thermal- and Photothermal-Induced Phase Change through Neutron Scattering
DOI: 10.1002/smll.202406019
RECENT PROJECTS
2024
Research Grant
Combatting Cardiovascular Diseases Using Innovative mRNA-based Therapies
2025
Research grants (other domestic)
Innovative Bioengineering of Nanodelivery Systems With mRNA-based Therapeutics for Inflammatory and Cardiovascular Diseases